Roche Plans Autonomous AI Labs to Speed Up Drug Development

My take: When a pharmaceutical company like Roche says its Phase III clinical trial success rate rose from 65% to over 80% so far this year, and credits part of that to AI supported decisions, it is worth paying attention. That is not a promise, those are results already showing up in a process as costly and slow as drug development.

What stands out is the model: Roche is not using AI to replace the lab, it is using it to run the lab better. The "lab in the loop" approach has AI predict, the lab test, and those results feed back into the model. That is AI as a strategic tool inside a real process, not magic doing the work on its own.

For anyone working with long trial and error processes (research, product development, quality control), the lesson applies just the same: AI performs better when it is built into the work cycle, not used off to the side.

Where in your work is there a trial and error cycle that could speed up if AI took part in every round, not just at the end?